NASDAQ$LIVN
LivaNova PLC · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
LIVN Q1 2024 — £295K revenue, 31.00 EPS
As a result, the Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by th. LivaNova PLC reported Q1 2024 results. Diluted EPS came in at 31.00. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: £295K.
- Diluted EPS: 31.00.
- Gross profit: £207K.
Headline financials
Revenue & EPS history
LivaNova · Revenue · Quarterly
$295M
Revenue by segment
LivaNova · $265M total across 3 segments · Q4 2022
- Cardiopulmonary$137M—51.5%
- Neuromodulation$127M—47.9%
- Other Revenue$1.6M—0.6%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
+1.2%
Avg return
Earnings day
+0.9%
Avg return
5 days after
+1.3%
Avg return
30 days after
58%
26 / 45 earnings
Positive
+23.3%
Q1 2025
Best reaction
-19.9%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +15.1% | +21.7% | +25.5% | |
| Q4 2025 | +0.8% | +1.8% | -10.4% | |
| Q3 2025 | -5.8% | -5.7% | +17.5% | |
| Q1 2025 | +23.3% | +28.6% | +30.7% | |
| Q4 2024 | -15.8% | -15.9% | -20.0% | |
| Q3 2024 | -2.5% | -7.5% | -0.9% | |
| Q2 2024 | -5.8% | -11.8% | -1.8% | |
| Q1 2024 | +12.9% | +12.3% | +9.5% | |
| Q4 2023 | +6.9% | +6.4% | +6.4% | |
| Q3 2023 | -0.8% | -0.9% | -6.4% | |
| Q2 2023 | +7.0% | +9.1% | +4.0% | |
| Q1 2023 | +0.6% | -0.0% | -0.6% | |
| Q4 2022 | -9.6% | -12.1% | -23.6% | |
| Q3 2022 | +2.2% | +6.6% | +19.1% | |
| Q2 2022 | -3.0% | -2.2% | -13.9% | |
| Q1 2022 | -13.2% | -21.8% | -9.1% | |
| Q4 2021 | +7.9% | +9.4% | +8.6% | |
| Q3 2021 | +15.3% | +15.9% | +2.4% | |
| Q2 2021 | +8.0% | +7.1% | +1.1% | |
| Q1 2021 | +3.8% | +1.4% | +0.8% | |
| Q4 2020 | +3.5% | +3.6% | +2.6% | |
| Q3 2020 | +1.0% | -4.5% | +8.9% | |
| Q2 2020 | -11.0% | -17.2% | -14.9% | |
| Q1 2020 | -5.8% | -10.4% | -5.1% | |
| Q4 2019 | +3.3% | +5.2% | -34.6% | |
| Q3 2019 | -6.8% | -6.4% | +10.4% | |
| Q2 2019 | +5.8% | +1.7% | +2.5% | |
| Q1 2019 | +5.2% | +8.8% | +4.4% | |
| Q4 2018 | -4.2% | -3.1% | +0.0% | |
| Q3 2018 | +5.6% | +6.9% | -6.6% | |
| Q2 2018 | +12.2% | +10.3% | +14.0% | |
| Q1 2018 | -8.0% | -6.7% | +5.9% | |
| Q4 2017 | +2.4% | +0.8% | +1.1% | |
| Q3 2017 | +11.7% | +9.1% | +20.3% | |
| Q2 2017 | +1.4% | +1.5% | +7.7% | |
| Q1 2017 | +4.0% | +4.8% | +7.0% | |
| Q4 2016 | +4.2% | -2.0% | -2.8% | |
| Q3 2016 | -19.9% | -21.0% | -19.3% | |
| Q2 2016 | +14.9% | +11.1% | +12.0% | |
| Q1 2016 | -3.5% | — | — | |
| Q4 2014 | -0.0% | — | — | |
| Q4 2013 | -0.0% | — | — | |
| Q4 2015 | -1.1% | — | — | |
| Q2 2015 | +1.9% | — | — | |
| Q3 2015 | -10.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro